References

1. Neville E, Mills RG, Jash DK, Mackinnon DM, Carstairs LS, James DG. Sarcoidosis of the upper respiratory tract and its association with lupus pernio.Thorax. 1976 ;31(6):660-4. PubMed | Google Scholar


2. Kikawada M, Ichinose Y, Kunisawa A, Yanagisawa N, Minemura K, Kasuga I et al. Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia. Respirology. 1998;3(1):41-4. PubMed | Google Scholar


3. Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid resistant sarcoidosis: Is antagonism of TNFalpha the answer?. ClinSci. 2007;112(5) :281-9. PubMed | Google Scholar


4. Ziegenhagen MW, Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Int Med. 2003;253(1):18-30. PubMed | Google Scholar


5. Guillevin Loïc, Meyer Olivier, Hachulla Éric, Sibilia Jean. Traité des Maladies et syndromes systémiques . 6th edition. 2016 Lavoisier SAS. PubMed | Google Scholar


6. Rodney Falk H, Raymond LMD, Comenzo MD, Martha Skinner MD. The Systemic Amyloidoses. N Engl J Med. 1997; 337(13):898-909. PubMed | Google Scholar


7. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJM et al. Amyloid fibril protein nomenclature: 2012 recommendations fromthe Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2012;19(4):167-70. PubMed | Google Scholar


8. Gómez-Puerta JA, Cervera R, Moll C, Solé M, Collado A, Sanmartí R. Proliferative lupus nephritis in a patient withsystemic lupus erythematosus and long standing secondary amyloid nephropathy. Clin Rheumatol. 2009 ;28(1):95-7. PubMed | Google Scholar


9. Monteiro P, Abreu P, Salvador MJ, Malcata A. Secondaryamyloidosis and systemic lupus erythematosus. Acta Reumatol Port. 2009;34(2B):400-4. PubMed | Google Scholar


10. Ridley MG, Maddison PJ, Tribe CR. Amyloidosis and systemic lupus erythematosus. Ann Rheum Dis .1984; 43(4):649-50. PubMed | Google Scholar